Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

MYNZ Mainz BioMed NV

0,66

0,001 (0,15%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Mainz BioMed NV (NASDAQ:MYNZ)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Mainz BioMed NV Charts.

Mainz BioMed NV (NASDAQ:MYNZ)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Mainz BioMed NV Charts.

News Mainz BioMed NV

Form D/A - Notice of Exempt Offering of Securities: [Amend]
Freitag 10 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
Dienstag 7 Mai 2024 (6 Tage vor) • GlobeNewswire Inc.

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
Donnerstag 25 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Mainz Biomed Reports Full Year 2023 Financial Results
Dienstag 9 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
Dienstag 19 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
Montag 18 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
Dienstag 12 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
Dienstag 5 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
Dienstag 27 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
Donnerstag 22 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
Mittwoch 21 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
Dienstag 6 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Mainz BioMed NV News-Artikel

Health Care Select Sector

BNP Paribas (QX)

Deutsche Telekom (QX)

JP Morgan Chase

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen